Skip to content

Clinical Study to Assess the Impact of a Bacterial- and Yeast-based Nutritional Supplement (AlcoDeTox) on Ethyl Alcohol Absorption in the Intestine Tract

Clinical Study to Assess the Impact of a Bacterial- and Yeast-based Nutritional Supplement (AlcoDeTox) on Ethyl Alcohol Absorption in the Intestine Tract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023744
Enrollment
24
Registered
2020-12-01
Start date
2020-09-28
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T51

Interventions

Group 1: Alcodetox (probiotic food supplement) 600mg probiotic material for 7 days in the morning for breakfast. Group 2: Placebo (capsules with rice flour) 7 days in the morning for breakfast

Sponsors

Peradil AB
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age > 18 years and = 75 years 2. Caucasian 3. Not suffering from any major disease 4. Willing to perform the two drinking experiments 5. No alcohol consumption within 7 days prior to study participation (negative EtG urine test 6. Negative Drug Screening test 7. Negative pregnancy test

Exclusion criteria

Exclusion criteria: 1. Acute or chronic disease 2. Present or History of alcohol addiction 3. Known allergy against probiotic nutritional supplements 4. Participation in a clinical trial within 3 months before trial entry. 5. Progressive fatal diseases 6. Participants taking medication (including non-prescription drugs) 7. Participants taking other dietary supplements 8. Past or current drug or alcohol abuse 9. Pregnancy or breast feeding 10. Lack of compliance or other similar reason, that, the investigator believes, precludes satisfactory participation in the study

Design outcomes

Primary

MeasureTime frame
Primary objective will be the impact of AlcoDeTox on plasma levels of alcohol after uptake of a high alcoholic beverage as compared to placebo after 7 days of nutritional intervention.

Secondary

MeasureTime frame
Investigation of the effect of the dietary supplement in comparison to placebo on: • breath alcohol levels after uptake of a high alcoholic beverage • cognitive function after uptake of a high alcoholic beverage • tolerability of the supplement (type and number of adverse events)

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026